Delivery Order SPE2DR25D2005-SPE2DR26FE7U8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,124.72 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,493.95 to AmerisourceBergen Drug Corp for the supply of Vaxelis vaccine syringes (0.5ml) under a firm fixed price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. Performance will be executed from the contractor's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,850.65 for Vaxelis vaccine syringes in 0.5ML quantities on December 1, 2025, with an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $15,207.41 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 0.5mL VAXELIS vaccine syringes, with a performance period through November 5, 2024. This Delivery Order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC...
- The Defense Logistics Agency awarded a $8,632.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) with a completion date of December 10, 2025. This non-set-aside contract was awarded on December 9, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,762.83 to AmerisourceBergen Drug Corp for the supply of Vaxelis vaccine syringes (0.5ml) under a firm fixed price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) under a firm fixed price contract with a ceiling value of $6,394.80. This non-competitive delivery order was issued on November 12, 2025, with an ultimate completion date of November 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order valued at $9,784.01 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) with a firm fixed price contract structure. The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order was awarded without set-aside designation through competitive procurement, demonstrating AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a delivery order valued at $5,791.57 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) on August 20, 2025, with completion scheduled for August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,394.80 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) with an ultimate completion date of June 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on June 18, 2025. The contractor's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7U8Delivery Order
The Defense Logistics Agency (DLA) awarded a $9,307.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on December 1, 2025, with completion scheduled for December 2, 2025. This non-set-aside delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical support vehicle for military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a comprehensive contract portfolio with the DLA Medical Supply Chain, supplying an extensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The SPE2DX IDC enables the company to fulfill diverse federal medical procurement requirements for organizations including the Defense Health Agency and U.S. Coast Guard. As a competitively awarded contractor with demonstrated capability to manage both small-value transactions and substantial orders, AmerisourceBergen serves as a critical vendor supporting military healthcare systems and federal medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 11/30/25 |